Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma

NCT02029313 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma and Allergic Rhinitis

Interventions

DRUG: Montelukast
DRUG: Montelukast sodium

Sponsor

PharmaKing